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Abstract
Simulating the evolution of the Human Immunodeficiency Virus (HIV) epi-
demic requires a detailed description of the population network, especially
for small populations in which individuals can be represented in detail and
accuracy. In this paper, we introduce the concept of a Complex Agent Net-
work(CAN) to model the HIV epidemics by combining agent-based modelling
and complex networks, in which agents represent individuals that have sexual
interactions. The applicability of CANs is demonstrated by constructing and
executing a detailed HIV epidemic model for men who have sex with men
(MSM) in Amsterdam, including a distinction between steady and casual
relationships. We focus on MSM contacts because they play an important
role in HIV epidemics and have been tracked in Amsterdam for a long time.
Our experiments show good correspondence between the historical data of
the Amsterdam cohort and the simulation results.
Key words: Multi-Agent Systems(MAS), Complex Network(CN), HIV
epidemics, scale-free, Men who have Sex with Men(MSM)
1. Introduction
Understanding the underlying dynamics in Human Immunodeficiency
Virus (HIV) epidemics is a crucial public health issue, unfortunately how-
ever addressing specific problems in small populations is difficult because
individuals need to be modelled with detailed social behavior. Traditional
∗Corresponding author
Email address: A.MeiShan@uva.nl, MeiShan@nudt.edu.cn (Shan Mei)
Preprint submitted to Mathematics and Computers in Simulation October 25, 2018
ar
X
iv
:0
81
2.
11
55
v2
  [
cs
.M
A]
  1
6 F
eb
 20
09
mathematical methods greatly simplify both the disease dynamics and the
population networks, however extending them to more detailed models is
intractable.
In particular, whether such methods also apply to networks of small size,
and thus to many real-world biological or epidemiological applications, is
still an open question[1]. Many networks of relevance to epidemiology may
be of relatively small size, among which social contact networks on sexually
transmitted diseases for a small group (e.g. men who have sex with men,
namely MSM, within a city or town) are representative.
Modelling the HIV epidemic is difficult because the true incidence1 of
the HIV/AIDS-epidemic is uncertain since many people may be unaware of
their infection. Secondly, HIV progression has a very long asymptomatic
period which makes studies of the actual infection spreading a very compli-
cated task [2]. Finally, the various routes of infection and the inhomogeneity
of the involved population pose additional challenges to understanding the
underlying knowledge of HIV epidemics.
Multi-agent systems (MAS) and complex networks (CN) are often used
separately to model and simulate epidemics; however, whether existing mod-
els, which typically focus on large populations, can address epidemics among
small groups (∼ 103-104) are still questionable and seemingly need further
validation. In terms of agent-based modelling, Teweldemedhin developed
an agent-based bottom-up modelling approach for estimating and predict-
ing theX spread of the HIV in a given population [3]; Xuan developed an
extended Cellular Automata simulation model to study the dynamical be-
havior of HIV/AIDS transmission by incorporating heterogeneity into agents’
behavior [4]. In terms of complex network modelling, Bai discussed a sexual
network spreading model for HIV epidemics [5]; Sloot proposed a new way
to model HIV infection spreading through the use of dynamic complex net-
works, with the time evolution of the network vertices modelled by a Markov
process [2].
In this paper we present the CAN approach for simulating epidemics in
small networks to great detail. The CAN is a hybrid approach in which multi-
agent systems and complex networks are the basic methods of modelling
1Incidence is a measure of the risk of developing some new condition within a specified
period of time. In this paper we use the incidence rate to denote the number of new
cases per unit of person-time at risk.
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epidemics on individual and population scales respectively. Using the CAN
approach, we simulate a relatively detailed model of the HIV endemic among
MSM in Amsterdam. This model includes a distinction between steady and
casual relationships, which is regarded as an important aspect by others [e.g.
6]. We compare the results to the Amsterdam Cohort Study (ACS) historical
data.
This paper is organized as follows. In Section 2 we review MASs and
complex networks and introduce the CAN approach. We describe the HIV
epidemic model in detail in Section 3 and simulation implementation in Sec-
tion 4. In Section 5 we discuss a case study and its simulation results.
2. Complex Agent Network
The CAN approach takes the MAS and CN as basic methods for mod-
elling and simulating epidemics on individual and population scales. Agents
contain specified personal information on an individual scale, whilst complex
networks emphasize the relationship dynamics among the agents on a popu-
lation scale. We review both concepts and the combination of them in this
section.
2.1. Multi-agent Systems
A MAS is a system composed of multiple interacting intelligent agents,
and can manifest self-organization and complex behavior even when the
individual strategies of all the agents are simple. Heylighen defined self-
organization as “the spontaneous emergence of global coherence out of the
local interactions between initially independent components” [7].
The agents in a multi-agent system have several important characteristics
[8]: Autonomy : the agents are at least partially autonomous. Local views :
no agent has a full global view of the system, or the system is too complex for
an agent to make practical use of such knowledge. Decentralization: there is
no controlling agent (or the system is effectively reduced to a reductionistic
system) [9].
Applied to HIV epidemics, a MAS represent a specified human commu-
nity and viruses propagate along social contacts. Each individual has his
own progression of infection and simple rules to choose partners. Each agent
only knows the information about himself and his partners instead of epi-
demiological statistics. There is no dominating agent in the community to
control the spread of viruses.
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2.2. Complex Networks
The study of complex networks is inspired largely by the empirical study
of real-world networks such as computer networks and social networks. A
network is a set of items, which we call vertices, with connections between
them, called edges [10]. In the context of network theory, a complex network
is a network with non-trivial topological features that mostly do not occur
in simple networks such as lattices.
The complex network theory aims to do three things[10]. Firstly, it aims
to find and highlight statistical properties, such as path lengths and de-
gree distributions, that characterize the structure and behavior of networked
systems, and to suggest appropriate ways to measure these properties. Sec-
ondly, it aims to create models of networks that can help us to understand
the meaning of these properties, how they came to be as they are, and how
they interact with one another. Finally, it aims to predict what the behavior
of networked systems will be, on the basis of measured structural properties
and the local rules governing individual vertices.
For HIV epidemics, an at-risk population can be depicted as a network
with vertices representing persons and edges representing social contacts.
Over these relationships, viruses are propagated from one individual to an-
other and thus give rise to the epidemic prevalence. Findings in sociology
or epidemiology suggest that social contact networks are scale-free networks
[11]. Therefore we create networks with vertices following power-law degree
distributions, and then simulate HIV propagation by evolving networks tem-
porally and spatially.
2.3. Complex Agent Networks
The benefits of combining a MAS and a CN is twofold.
Firstly, the edge forming and rewiring mechanism of a complex network
with a non-trivial topology can regulate the interactions among agents in a
MAS. In this way we can keep these interactions from being either purely
regular or purely random as we usually see in a MAS. Furthermore, the
recent development of statistical methods for quantifying complex networks
is a way to analyze the influence of network topologies on epidemics [e.g. 12].
Secondly, local agent information can be combined to infer global statis-
tics which can be fed back into the simulation dynamically, resembling real-
world epidemics more closely. For example, if the HIV prevalence becomes
very high, individuals may be less prone to unsafe sexual interactions with
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Figure 1: Complex Agent Networks
other individuals whose serostatus they do not know.2 This interaction of
both the individual and population levels is depicted in Figure 1.
To combine the MAS and CN we map agents and their interactions in a
MAS to vertices and edges in a CN, respectively, as shown in Fig. 1. Agents
provide personal heterogeneity and local infection progression on an individ-
ual level; networks benefit from continuously distilling values of epidemic-
related parameters from individuals and then mimic the virus propagation
on a population level.
2.4. Application of CAN to HIV epidemics
Fig. 2 shows an application reference procedure of applying the CAN
approach to HIV epidemics, which consists of four steps, i.e. data collection,
modelling, simulation and result manipulation.
The CAN-based HIV epidemic studies commence with data collection
from e.g. Clinical Databases, Internet Data Mining, Literature and Ques-
tionnaires.
Fed with the data, models are constructed by utilizing the features of
both the MAS and CN, which are depicted by two composite blocks. The
“MAS” composite block deals with societal individuals and their infection
details. An Agent stands for an individual and supports specialized inheri-
tance. As shown in Fig. 2, an inherited block MSM Agent manages MSM’
2Here we assume that individuals somehow find out such global statistics, e.g. through
media.
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Figure 2: Application reference procedure of Complex Agent Network
infection properties and status transitions by using HIV Progression and
Treatment blocks. A MSM Agent also support inferring values of parameters
for a “CN ”. The Treatment block considers factors related to HIV ART or
HAART3 (e.g. drug types, patients’ adherence and drug resistances [13]).
The “CN ” composite block manipulates network initializing, reshuffling and
measuring through the Network and Network Measurement blocks. In ad-
dition, the “CN ” provides network rendering support for the Visualization
block of simulation.
The Visualization and Checkpoint blocks can be invoked by the Simu-
lator according to specified purposes, to enhance interactive exploration of
simulations.
The Statistics and Analysis blocks are applied to simulation results and
then enforce the GUI Update of network rendering and parameter plotting.
3. Modelling HIV Epidemics
3.1. Progression of HIV infection
The progression of HIV infection from seropositive to AIDS can broadly
be divided into three stages: primary infection (PI), asymptomatic period
(AP) and AIDS. Although there are much variations amongst patients, on
3ARV, Anti-Retroviral Therapy; HAART, Highly Active Anti-Retroviral Therapy, is
the combination of at least two different classes of antiretroviral drugs.
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average, transmissibility is the highest during the primary infection which is
believed to be associated with high plasma HIV RNA levels and continued
risky sexual activities [14, 15].
Correspondingly each agent representing an at-risk individual, possesses
a disease manager to conduct its HIV infection progression temporally. The
manager conducts an irreversible “negative ⇀ PI ⇀ AP ⇀ AIDS” order.
Note that, we exclude the case that an individual with AIDS can with the
right treatment go back to the asymptomatic phase, because in general pa-
tients are most likely diagnosed and treated before reaching the AIDS stage.
3.2. Construction of contact networks
HIV is transmitted mainly through sexual contacts, intravenous drug uses
(IDU), mother-to-child transmissions and transfusion of contaminated blood
products. In this paper we focus on MSM contacts which play an important
role in HIV epidemics and have been tracked in Amsterdam for a long time
[e.g. 16, 17]. We model these contacts as an undirected, scale-free complex
network.
The sexual contact network starts withN0 MSM, each of which is assumed
to be sexually active with an age between 15 and 65 based on the age limits
of the ACS samples [17]. The network is assumed to be scale-free [11, 18],
whilst the degree k of each vertex follows a degree distribution pk ∼ k−γ to
represent his yearly number of partners. Let us choose
pk =
{
Ck−γ for k ≥ 1
p0 for k = 0
(1)
where γ and p0 are constants and C is a normalizing factor.
After obtaining the degree sequence of vertices, edges(partnerships) are
formed by using the so-called configuration model [10]. A degree sequence is
a set of n values of the degrees ki of vertices i = 1, ..., n, from the given power-
law distribution. According to the configuration model, the probability that
a vertex is chosen as an end of a random edge is proportional to kpk.
Different from most previous studies on epidemics in static networks,
our networks evolve with simulation time steps, which is driven by the HIV
epidemic dynamics depicted in Section 3.3 and 3.4. Further implementation
will be discussed in Section 4.2.
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3.3. HIV propagation in networks
The HIV propagation in networks can become considerably difficult when
more details are taken into account. We provide a formula of calculating the
transmission probability, considering risk behavior, treatments, (steady or
casual) partnerships and transmissibility at different infection stages.
Similar to the commonly used Susceptible-Infected-Removed (SIR) epi-
demiological model, our model sets individuals in three discrete states, i.e.
susceptible, infected or removed (caused by deaths). The infected state com-
prises primary infection, asymptomatic period and AIDS stages (see Section
3.1) which are related with different statistical transmission probability (TP )
per action. These TP per action are represented by TPPI, TPAP and TPAIDS
for PI, AP and AIDS stages, respectively. Individuals at stage AIDS are
assumed to have no contacts, so that TPAIDS = 0.
Each individual Vi has ki partners, among whom at most one steady
partner is allowed. This steady partnership lasts for years based on statistical
data. With the presence of a steady partner, an individual is likely to reduce
his risk behavior with all other casual partners, and this possible reduction is
represented as a partnership factor. Two steady partners have many actions
per year, while two casual partners have one action per year.
For a vertex Vi, the statistical transmission probability per action is de-
noted by TPi. Then this transmission probability per action is adjusted
according to the stage an individual is currently at, and the treatment re-
duction factor FTi which is derived from treatment effectiveness.
For an edge Eij as a partnership connecting Vi and Vj, the risk behavior
factor is denoted by FRij , which is related to the partners’ attitude towards
risk; the number of actions per year over this partnership is denoted by NAij
(NAij = NAji , ∀i, j).
In addition, the partnership factor denoted by FPj is subjected to whether
the individual Vj has a steady partner, and it will influence all incident casual
partnerships.
Then the transmission probability from Vi to Vj per action is given based
on parameters aforementioned
PTAij = FPj ∗ FRij ∗ (FTi ∗ TPi) (2)
Because the PI stage lasts around 3 months (0.25 year) and falls short
of one time step of a year, we divide TPPI into TPPI,1 and TPPI,2 as two
transmissibility at PI stage. Hence if Vi is at the PI stage, we also divide
PTAij into PTAij ,1 and PTAij ,2, and NAij into NAij ,1 and NAij ,2. Then
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PTAij ,1 = FPj ∗ FRij ∗ (FTi ∗ TPi,1),
PTAij ,2 = FPj ∗ FRij ∗ (FTi ∗ TPi,2).
The transmission probability from Vi to Vj per year is
PTYij =

0 HIV negative Vi
0.25 ∗ PTAij ,1 + 0.75 ∗ PTAij ,2 PI Vi and casual Eij
1− (1− PTAij ,1)NAij,1 ∗ (1− PTAij ,2)NAij,2 PI Vi and steady Eij
PTAij AP Vi and casual Eij
1− (1− PTAij)NAij AP Vi and steady Eij
0 AIDS Vi
(3)
The probability of Vi infected by positive partners per year is
PTYi = 1−
ki∏
m=1
(1− PTYmi) (4)
where ki is the number of partners of Vi.
Note that TPi, FTi and FPi are varying with the status of Vi and time,
and so are FRij and NAij with the status of Eij and time. Therefore each
susceptible vertex gets infected with a probability given by Equation 4 at
each time step, which contributes to the dynamics of HIV propagation.
3.4. Demographic influences
In this section, we discuss the demographic principles that regulate the
conservation or deletion (substitution) of individuals and relationships.
The vertices in networks are initialized randomly with an age from a range
of 15 to 65, according to the age limits of the ACS samples [17]. Each edge is
initialized with an expected duration according to the statistical real-world
partnership duration. At each time step, an individual gets an increment of
age and a partnership gets an increment of duration, mimicking the reality.
If one of the following three conditions applies, then an individual will be
removed from a network:
(1) The individual’s age exceeds 65, the upper age limit of the ACS sam-
ples.
(2) The infection has developed to the AIDS stage (the individual will be
removed at the next time step).
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(3) In case of geographic migration (a fraction of randomly selected indi-
viduals will be removed from a network. This fraction is left as tunable, e.g.
1% assumed in our model.).
Susceptible individuals will be added to the network as substitutes for the
removed individuals at each time step, to keep the population size constant.
All these newly added individuals will join the epidemic contact network
according to the principles given in Section 3.2.
An edge will be kept for the next time step if:
(1) It is a steady partnership and has not expired.
(2) A previous casual partnership is likely to be conserved with a proba-
bility (e.g. 0.2 assumed in our model).
4. Simulation Implementation
We implement specific functionalities of the HIV epidemics simulation,
such as an advanced scheduling mechanism and interactive visualization,
using the JUNG[19] and MASON[20] libraries.
4.1. Functionality
The specific functionalities of the CAN simulation contains the following
components:
(1) Model interpretation
The model described in Section 3 is interpreted into an executable simu-
lation supporting the population and individual scales.
On a population scale, the formation and reshuffle of the edges are driven
by the dynamics of the networks. An edge is formed based on the degrees
and local status of two potential partners, as well as the (steady or casual)
type and duration of their partnership.
On an individual scale, heterogenized agents are described with different
HIV progression stages (Susceptible, PI, AP and AIDS) which are influenced
per time step by the disease progression, risk behavior and treatment.
Furthermore, the interpreted executable simulation consists of modules
which we call operators (see Section 4.2). We embed these operators into
either agents or networks, and then schedule them using a simulator.
(2) Simulator
We implement a flexible scheduling mechanism, interactive visualization
and a checkpoint mechanism into the simulator. The scheduling mechanism is
double-precision discrete-event-and-priority driven and supports complicated
10
Table 1: Simulation operators
Operator Scale Priority Description
Infection
Operator
Population 0
Infect susceptible individuals
and propagate HIV.
Local
Progression
Operator
Individual 1
Advance HIV disease progression
of individuals.
Demographic-
Reshuffling
Operator
Population 2
Enforce demographic and
reshuffling influences on network
evolutions.
Statistics and
Visualization
Population 3
Statistics approaches and
visualization updates can be
added and configured according
to pre-specified outputting rules.
user interactions with the simulator. This gives support to interactive explo-
ration of the running simulations and, for instance, allows checkpoint/restart
of long running simulations.
(3) Statistics and analysis
We can take specific epidemic-related statistics and analyze their results,
besides general statistical properties e.g. path lengths. For example, we take
incidence per person-year as a measure of HIV epidemics in Section 5, by
dividing the number of newly infected persons every year by the population
size.
4.2. Operators
The simulation operators with their annotated priorities are shown in
Table 1. These operators are invoked at each time step to evolve a network
N [t] = 〈V [t], E[t]〉 where t is the time step.
The Infection Operator basically deals with virus propagation on a popu-
lation scale. For simplification, we disseminate its calculation to individuals
by using Equations 2-4 in Section 3.3. Algorithm 1 gives the details.
The Local Progression Operator and Demographic - Reshuffling Operator
are presented in Algorithms 2 and 3 respectively.
11
Algorithm 1 Infection Operator
Input: Network N = 〈V,E〉
Output: The evolved network N with some vertices newly infected.
Infect susceptible vertices.
for Vi ∈ V do
if Vi is susceptible then
Judge whether Vi has any steady partnership
Calculate PTYi using Equations 2-4
if a generated random number < PTYi then
Set the infection stage of Vi to Primary Infection.
end if
end if
end for
Algorithm 2 Local Progression Operator
Input: Network N = 〈V,E〉
Output: The evolved network N .
Make vertices and edges progress.
for Vi ∈ V do
Vi.Age++
if Vi is infected then
if Vi.CurrentStage.LastingPeriod <
Vi.CurrentStage.ExpectedDuration then
Vi.CurrentStage.LastingPeriod++
else
Vi progresses to next stage i.e. PI→AP or AP→AIDS.
end if
end if
end for
for Ei ∈ E do
if Ei is a steady partnership then
if Ei.LastingPeriod< Ei.ExpectedDuration then
Ei.LastingPeriod++
end if
end if
end for
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Algorithm 3 Demographic-Reshuffling Operator
Input: Network N = 〈V,E〉
Output: The evolved network N .
Evolve the network demographically.
for Vi ∈ V do
Remove Vi according to the rules in Section 3.4.
end for
Add new susceptible vertices to substitute removed ones.
for Ei ∈ E do
Remove Ei according to the rules in Section 3.4.
end for
Reshuffle all edges according to the rules in Section 3.2.
4.3. Simulation scheduling
We design and implement a flexible scheduling mechanism with three
main advantages.
Firstly, a double-precision discrete-event based scheduler is available.
With this we can schedule special events, such as the Gay Parade Day4
parties for MSM happening at fractional time steps.
Secondly, all agents and operators can be registered with predefined pri-
orities. Vertices (agents) and edges (partnerships) are scheduled firstly, (de-
mographical and reshuffling) dynamics of networks secondly, and statistics
and GUI updates finally. In this way, the infection and local progression
drives the dynamic evolution of networks and the collection of statistics.
Finally, the simulator can schedule, for special purposes, vertices and
edges at predefined intervals. For example, we can collect incidence statistics
every 2 years instead of 1 year.
4.4. Visualization
The visualization of contact networks can present an overview of the
studied population, and explain details about a selected vertex or edge. The
visualization serves the following purposes:
4The Gay Parade Day is the national celebration day on the first weekend in August
in the Netherlands.
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Figure 3: Initialization(a) and After reshuffling(b) in the Amsterdam MSM simula-
tion (The green, red, blue and black circles represent the susceptible group, the primary
infection group, the asymptomatic group and the AIDS group, respectively; Solid and
dotted lines represent steady partnerships and casual partnerships, respectively; small,
medium and large circles represent vertices with a degree less than 50, between 50 and
100, and greater than 100, respectively.)
(a) Initialization (b) After reshuffling
(1) To represent individuals in a population and (steady or casual) rela-
tionships.
(2) To arrange and display vertices and edges, in order to study the
sorting, grouping and correlation of vertices and edges.
(3) To present detailed properties of selected vertices or edges.
Fig. 3 shows the visualization of the network after initialization and
reshuffling.
5. Case Study: the HIV epidemic in the Amsterdam MSM cohort
We take the HIV epidemic among the Amsterdam MSM cohort as a case
study.
5.1. Amsterdam cohort study
The Amsterdam Cohort Study (ACS) of HIV infection and AIDS among
MSM was initiated in 1984. According to the report [16], 2299 MSM have
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been involved in the ACS until 2006. Of the 2299 MSM, 571 were HIV-
positive at study entry and 192 seroconverted during follow-up. Yearly HIV
inicidence for MSM over calendar years is reported in [17] to indicate the
HIV prevalence trend among MSM.
5.2. Parameters and their values
5.2.1. On a population scale
Societal-related parameters for individuals and network-related initializa-
tion are discussed.
Schneeberger concluded in [11] that MSM population follows a power-law
degree distribution with a value of γ in the interval between 1.5 and 2. We
assume γ = 1.6 and a maximum degree kmax = 200. For initialization, the
network size is N0 = 2299, and the fraction of vertices with a degree of 0 is set
to be p0 = 0.01 because we assume a small portion of people in a population
not having any contact.
Steady relationships among MSM have a higher contribution to HIV in-
cidence in the era of HAART because more unprotected anal sex is likely
to take place between steady couples other that casual ones, according to
[15, 6, 21, 22, 23]. Thus the fraction of steady relationships in a network is
regarded as an important parameter. Based on questionnaire results given
by [6], approximately 50% of the ACS participants reported having a steady
partner. So we estimate that a partnership is initialized as a steady one with
a probability given by
Psteady = N ∗ (0.5/2)/ 〈e〉 (5)
where
〈k〉 =
kmax∑
k=0
kpk,
〈e〉 = N ∗ 〈k〉 /2
N is the size of a network, 〈e〉 is the expected total number of edges in
a network and 〈k〉 is the expected degree of vertices. According to Equation
1 with given values of γ and kmax, we get Psteady ≈ 0.054. Allowing for
steady partnerships being kept until expired, the averaged fraction of steady
relationships from our simulation results fluctuates between 0.047 and 0.055.
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The duration of steady partnerships among Amsterdam MSM is reported
to have an expected value of 1.5 years [6]. Thus we assume the duration of
steady partnerships following a discrete uniform distribution DU(1, 2).
Unlike the PI or AIDS stages with fixed durations, the duration of the
AP stage can vary with the therapy effecitiveness. So we draw the duration
of AP from a Poisson distribution with a mean value of 13 years for a failed
treatment, and a mean value of 22 years for a successful treatment [6].
The transmission probability for sexual actions other than UAI5 is as-
sumed to be negligible[24], also, the transmission probability for an UAI
between serodiscordant6 men is depending on whether the role of the HIV-
negative man is receptive (URAI) or insertive (UIAI). We assume each part-
ner of a couple takes randomly a receptive or insertive role in an action. The
frequency of either URAI or UIAI between steady partners is 15 per year[6],
for simplicity we assume that the frequency of sexual actions of MSM per
year follows a Poisson distribution of P(30). At the PI stage, the frequency
within the first 3 months and the last 9 months is assumed to follow P(8)
and P(22), respectively.
5.2.2. On an individual scale
Epidemic parameters and the involved reduction factors are discussed.
Of the infected individuals at the asymptomatic stage, 42% know they
are HIV positive[6]. Since the introduction of HAART in 1996, the fraction
of individuals that has received any form of HAART therapy after diagnosis,
is 81% in 2006 [16]. 70% of the individuals who received therapy will be
successfully treated[6]. In other words, individuals get diagnosed with a
probability of 0.42, and obtain a treatment with a probability of 0.81, and
then get successfully treated with a probability of 0.7.
The value of TPi (see Section 3.3) is related to the infection stage of
an individual Vi, given by TPPI,1, TPPI,2, TPAP or TPAIDS. According to
5UAI, unprotected anal intercourse; URAI, unprotected receptive anal intercourse;
UIAI, unprotected insertive anal intercourse
6Serodiscordant (sero-discordant) is a term used to describe a couple in which one
partner is HIV positive and the other is HIV negative (Smith, Raymond. Couples. Re-
trieved on 08-26, 2006.). Seroconcordant is the term used to describe a couple in which
both partners are of the same HIV status (ie both are HIV positive or both are HIV
negative).
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Table 2: The yearly relative values of risk behavior factor for HIV negative and positive
MSM. * - The value in 1987 is an average of its adjacent years (1986 and 1988), so is that
in 1996. ** - The baseline with value 1.00.
1985-1986 1987 1988-1991 1992-1995 1996 1997-1999 2000-
negative 3.50 2.50∗ 1.50 0.80 0.90 1.00∗∗ 1.30
positive 2.80 1.61 0.42 0.88 0.78 0.70 1.30
[25, 26, 27], the probability of the transmission per URAI/UIAI act at stage
PI and AP is 0.22/0.044 and 0.011/0.0022 respectively. Therefore, TPPI,1 =
0.22/0.044 and TPPI,2 = TPAP = 0.011/0.0022 with respect to the receptive
or insertive role.
ART is assumed to reduce the transmissibility by 50-90% to a moderate
extent in [28], so that in our simulations the treatment factor FTi is set to
follow a continuous uniform distribution CU(0.1, 0.5). If an individual has a
steady partner, the partnership factor FPi is 0.84[see 6, Sec. 2], otherwise 1
which means no reduction.
The general use of ART leading to changes in risk behavior has sparked
considerable concerns, for instance, Baggaley discussed in [15] that increases
in risk behavior could result from increased optimism about HIV therapy
due to the availability of HAART. In our simulations, the definition and
estimated values of risk behavior factors FRij is based on [29, 30], and the
relative values are given in Table 2.
5.3. Results and discussion
The simulation results illustrated in Figure 4 shows the HIV incidences
(a) and AIDS diagnosis cases (b) over calendar years.
We used mainly the incidence for comparison and validation because of
its relative dimension. Our simulated yearly incidences are consistent with
the historical ACS data [see 17, Table 5], based on the conduct of a null
hypothesis test where the simulation result of incidence does not differ sig-
nificantly from the ACS data. Although the historical data (the dashed line
in Figure 4a), got based on incomplete statistics (due to the involvement of
subgroups of MSM related to substudies of ACS in years), was fluctuating
tremendously, the hypothesis is accepted by using Chi-Square tests with a
significance level of 0.05 (data not shown).
As a supplement, we compared the simulated AIDS diagnosis cases with
the historical statistics in the Netherlands in the aspect of trend. Our result
17
Figure 4: Simulation results (averaged on 24 executions) versus statistical historical data
of HIV incidence (ACS)(a) and AIDS diagnoses cases (in Netherlands, not only in Ams-
terdam)(b) over calendar years
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shows, even that it is based on a relatively small sample space with 2299
Amsterdam MSM, a similar trend to the statistical data in the Netherlands
(including Amsterdam as one city) over calendar years [see 31, Table B.18].
Both the two curves in Figure 4b approximately show a continuous increase
in AIDS diagnosis cases until 1996 and an acute decline in 1996-1998, and
then keeps stable from 1999 on. In this study, our simulation suggests that
the acute decline is most likely caused by the introduction of HAART in
1996. In the future, we could scale up the simulation of AIDS diagnosis
cases from Amsterdam to the Netherlands, if and when the total numbers of
MSM with different behavior features in different cities of Netherlands are
available.
6. Conclusions
We proposed a flexible hybrid Complex Agent Network approach and
validated experimentally its applicability by taking the dynamics of HIV
propagation among Amsterdam MSM, a representative small population, as a
case study. Our experiments showed good correspondence between the model
results and the historical data of ACS, in addition, the results are robust
with respect to small changes in the input parameters (data not shown).
Therefore, the model can be adopted to predict the future trend of HIV
18
prevalence among MSM in Amsterdam, whilst allowing for easy tuning the
values of highly concerned parameters, such as the drug effectivity, diagnosis
proportion and risk behavior factor.
7. Acknowledgments
The authors would like to acknowledge the financial support of the China
Scholarship Council (www.csc.edu.cn) and the European ViroLab [32] (www.virolab.org)
grant INFSO-IST-027446.
References
[1] M. Pautasso and M. J. Jeger, Ecological Complexity 5, 1 (2008).
[2] P. M. A. Sloot, S. V. Ivanov, A. V. Boukhanovsky, D. A. M. C. Van
De Vijver, and C. A. B. Boucher, International Journal of Computer
Mathematics 85, 1175 (2008).
[3] E. Teweldemedhin, T. Marwala, and C. Mueller (2005), Proceedings -
HIS’04: 4th International Conference on Hybrid Intelligent Systems, pp.
154–159.
[4] H. Xuan, L. Xu, and L. Li, Annals of Operations Research pp. 1–19
(2008), article in Press.
[5] W. . Bai, T. Zhou, and B. . Wang, International Journal of Modern
Physics C 18, 1025 (2007).
[6] M. Xiridou, R. Geskus, J. De Wit, R. Coutinho, and M. Kretzschmar,
AIDS 17, 1029 (2003).
[7] H. F., The science of self-organization and adaptivity (2001).
[8] M. Wooldridge, ed., An Introduction to MultiAgent Systems (John Wiley
& Sons Ltd, 2002).
[9] L. Panait and S. Luke, Autonomous Agents and Multi-Agent Systems
11, 387 (2005), 10.1007/s10458-005-2631-2.
[10] M. E. J. Newman, SIAM Review 45, 167 (2003).
19
[11] A. Schneeberger, R. Nat, C. H. Mercer, S. A. J. Gregson, N. M. Fer-
guson, C. A. Nyamukapa, R. M. Anderson, A. M. Johnson, and G. P.
Garnett, Sexually Transmitted Diseases 31, 380 (2004).
[12] S. M. Goodreau, Genetics 172, 2035 (2006).
[13] P. M. A. Sloot, A. V. Boukhanovsky, W. Keulen, A. Tirado-Ramos, and
C. A. Boucher, Journal of Clinical Monitoring and Computing 19, 263
(2005).
[14] J. S. Koopman, J. A. Jacquez, G. W. Welch, C. P. Simon, B. Foxman,
S. M. Pollock, D. Barth-Jones, A. L. Adams, and K. Lange, Journal of
Acquired Immune Deficiency Syndromes and Human Retrovirology 14,
249 (1997).
[15] R. F. Baggaley, N. M. Ferguson, and G. P. Garnett, Emerging Themes
in Epidemiology 2 (2005).
[16] The amsterdam cohort studies on hiv in-
fection annual report 2006 (2006), URL
http://www.amsterdamcohortstudies.org/menu/reports/ACSannualreport2006.pdf.
[17] Overview of the amsterdam cohort studies among
homosexual men and drug users (2006), URL
http://www.amsterdamcohortstudies.org/menu/reports/ACSoverview2006.pdf.
[18] W. J. Reed, Mathematical Biosciences 201, 3 (2006).
[19] J. O’Madadhain, D. Fisher, P. Smyth, S. White, and Y.-B. Boey, Journal
of Statistical Software (2005).
[20] S. Luke, C. Cioffi-Revilla, L. Panait, and K. Sullivan, Proceedings of the
2004 SwarmFest Workshop (2004).
[21] M. Xiridou, R. Geskus, J. De Wit, R. Coutinho, and M. Kretzschmar,
AIDS 18, 1311 (2004).
[22] S. J. Semple, T. L. Patterson, and I. Grant, AIDS Care - Psychological
and Socio-Medical Aspects of AIDS/HIV 15, 3 (2003).
[23] U. Davidovich, J. B. F. De Wit, and W. Stroebe, AIDS Education and
Prevention 16, 304 (2004).
20
[24] C. F. Caceres and G. J. P. Van Griensven, AIDS 8, 1051 (1994).
[25] B. Leynaert, A. M. Downs, and I. De Vincenzi, American Journal of
Epidemiology 148, 88 (1998).
[26] E. Vittinghoff, J. Douglas, F. Judson, D. McKirnan, K. Macqueen, and
S. R. Buchbinder, American Journal of Epidemiology 150, 306 (1999).
[27] V. DeGruttola, G. R. Seage Iii, K. H. Mayer, and C. R. Horsburgh Jr,
Journal of Clinical Epidemiology 42, 849 (1989).
[28] M. C. Boily, F. I. Bastos, K. Desai, and B. Masse, Sexually Transmitted
Diseases 31, 100 (2004).
[29] N. H. T. M. Dukers, J. Goudsmit, J. B. F. De Wit, M. Prins, G. J.
Weverling, and R. A. Coutinho, AIDS 15, 369 (2001).
[30] D. Bezemer, F. De Wolf, M. C. Boerlijst, A. Van Sighem, T. D.
Hollingsworth, M. Prins, R. B. Geskus, L. Gras, R. A. Coutinho, and
C. Fraser, AIDS 22, 1071 (2008).
[31] M. v. Veen, F. Koedijk, I. v. d. Broek, E. O. d. Coul, I. d.
Boer, A. v. Sighem, and M. v. d. Sande, Sexually trans-
mitted infections in the netherlands in 2006 (2006), URL
http://rivm.openrepository.com/rivm/bitstream/10029/16495/1/210261003.pdf.
[32] P. M. A. Sloot, P. Coveney, M. T. Bubak, A.-M. Vandamme, B. . Nu-
allain, D. v. d. Vijver, and C. Boucher, Reviews in Antiviral Therapy 3
(2008).
21
